Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-06

Clinical Trial Update: Long Term Chamomile Therapy for Anxiety [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term chamomile therapy for generalized anxiety disorder has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chamomile (Chamomile extract (Matricaria chamomilla))

Snippet

Sponsor: University of Pennsylvania | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-07-06